Peter C. Brandt
CIK 1434099 · CEO · last filed 2026-05-12
Peter C. Brandt is a CEO who has filed 44 SEC Form 4 insider transactions across 5 companies since 2008. The most recent filing, for INAB, was dated May 12, 2026. Across all open-market trades the lifetime net is +$1.3M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $141.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$141.1K
5
44
$1.31M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INAB | Director | 98,690 | $1.43 | $141.1K | $200.0K | 13 | 2026-05-12 |
| Opus Genetics, Inc. (RNN) Delisted | Director | 150,000 | — | — | $171.0K | 11 | 2019-06-07 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Director | 0 | — | — | $201.0K | 6 | 2015-01-30 |
| EPOCRATES INC (EPOC) Delisted | CEO | 0 | — | — | $242.4K | 7 | 2013-03-13 |
| NOVEN PHARMACEUTICALS INC (NOVN) Delisted | President and CEO | 0 | $0.09 | $0 | $492.7K | 7 | 2009-08-27 |
Recent Filings
44 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-12 | INAB | Grant (A) | — | $0 | EDGAR |
| 2025-12-23 | INAB | Grant (A) | +72,464 | $100.0K | EDGAR |
| 2025-05-12 | INAB | Grant (A) | — | $0 | EDGAR |
| 2025-05-07 | INAB | Mixed | +163,934 | $30.2K | EDGAR |
| 2024-12-23 | INAB | Grant (A) | — | $0 | EDGAR |
| 2024-10-08 | INAB | Mixed | +253,164 | $0 | EDGAR |
| 2024-06-14 | INAB | Grant (A) | — | $0 | EDGAR |
| 2023-12-15 | INAB | Grant (A) | +81,967 | $0 | EDGAR |
| 2023-06-16 | INAB | Grant (A) | — | $0 | EDGAR |
| 2022-09-23 | INAB | Grant (A) | — | $0 | EDGAR |